Alembic Pharma passes Brazilian health regulator audit at Panelav API-II facility for eight APIs

Alembic Pharma Share Price | The Brazilian Health Regulatory Agency (ANVISA) GMP audit was conducted from September 16, 2024 to September 20, the company said.

Leave a Reply

Your email address will not be published. Required fields are marked *